Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Andreas Bruchbacher"'
Autor:
Bettina Trimmel, Andre Oszwald, Christoph Diemand, Iris E. Ertl, Ursula Lemberger, Andreas Bruchbacher, Robert Brettner, Stephan Korn, Irene Resch, Eva Comperat, Shahrokh F. Shariat, Melanie R. Hassler
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Squamous cell carcinoma of the penis (PSC) is a rare disease with limited information on the molecular events leading to malignant transformation. In a third of PSC cases, presence of human papilloma virus (HPV) is found. The APOBEC3 family
Externí odkaz:
https://doaj.org/article/3aa2b5c569dc4bdc90c7d05d36bb9d7e
Autor:
Dafina Ilijazi, Walter Pulverer, Iris E. Ertl, Ursula Lemberger, Shoji Kimura, Mohammad Abufaraj, David D’Andrea, Benjamin Pradere, Andreas Bruchbacher, Anna Graf, Francesco Soria, Martin Susani, Andrea Haitel, Luca Molinaro, Armin Pycha, Evi Comploj, Stephan Pabinger, Andreas Weinhäusel, Gerda Egger, Shahrokh F. Shariat, Melanie R. Hassler
Publikováno v:
Cells, Vol 9, Iss 8, p 1839 (2020)
Background: Bacillus Calmette-Guérin (BCG) immunotherapy, the standard adjuvant intravesical therapy for some intermediate and most high-risk non-muscle invasive bladder cancers (NMIBCs), suffers from a heterogenous response rate. Molecular markers
Externí odkaz:
https://doaj.org/article/837a12d883f24e87bf5c66e235db5396
Autor:
Iris E. Ertl, Ursula Lemberger, Dafina Ilijazi, Melanie R. Hassler, Andreas Bruchbacher, Robert Brettner, Hannah Kronabitter, Michael Gutmann, Petra Vician, Gerhard Zeitler, Anna Koren, Charles-Hugues Lardeau, Thomas Mohr, Andrea Haitel, Eva Compérat, André Oszwald, Gabriel Wasinger, Thomas Clozel, Olivier Elemento, Stefan Kubicek, Walter Berger, Shahrokh F. Shariat
Publikováno v:
European Urology. 82:261-270
The heterogeneity of bladder cancers (BCs) is a major challenge for the development of novel therapies. However, given the high rates of recurrence and/or treatment failure, the identification of effective therapeutic strategies is an urgent clinical
Publikováno v:
Current Opinion in Urology. 31:147-154
Purpose of review Urinary tract infection (UTI) is one of the most common pediatric infections worldwide. Recently introduced 16S rRNA sequencing allows detailed identification of bacteria involved in UTI on a species-based level. The urogenital micr
Autor:
Ekaterina Laukhtina, Ursula Lemberger, Andreas Bruchbacher, Dafina Ilijazi, David D’Andrea, Martin Susani, Dmitry Enikeev, Eva Compérat, Shahrokh F. Shariat, Melanie R. Hassler
Publikováno v:
Journal of Urology. 207
Autor:
Stefano Luzzago, Benjamin Pradere, Manuela Schmidinger, Shahrokh F. Shariat, Pierre I. Karakiewicz, Hadi Mostafaei, Keiichiro Mori, Andreas Bruchbacher, Noriyoshi Miura, Shin Egawa
Publikováno v:
Cancer Immunology, Immunotherapy
Purpose Management of metastatic renal cell cancer (mRCC) has undergone a paradigm shift with immune-checkpoint inhibitors (ICI) in the first-line setting. However, direct comparative data are inadequate to inform treatment decisions. Therefore, we a
Autor:
Stephan Brönimann, Shahrokh F. Shariat, Andreas Bruchbacher, Melanie R. Hassler, Ursula Lemberger
Publikováno v:
Current Opinion in Urology. 30:519-526
Purpose of review The aim of this article is to give an overview of poly(ADP-ribose) polymerase inhibitors (PARPis) trials in prostate cancer and to discuss emerging approaches with potential future clinical implementation in both prostate and urothe
Autor:
Melanie R. Hassler, Harun Fajkovic, Ursula Lemberger, Manuela Schmidinger, Andreas Bruchbacher
Publikováno v:
Current Opinion in Urology. 30:534-541
Purpose of review The aim of the article to summarize recent changes of treatment options in metastatic renal cell carcinoma (mRCC) with a special emphasis on immune checkpoint inhibition. Recent findings The introduction of checkpoint inhibitor (CPI
Autor:
Stephan Korn, Melanie R. Hassler, Shahrokh F. Shariat, Ekaterina Laukhtina, Martin Susani, Andreas Bruchbacher, Dmitry Enikeev, Florian Berndl, Dafina Ilijazi, Ursula Lemberger, David D'Andrea, Eva Compérat
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 1147, p 1147 (2021)
Journal of Personalized Medicine
Volume 11
Issue 11
Journal of Personalized Medicine
Volume 11
Issue 11
The gene coding for histone methyltransferase KMT2D is found among the top mutated genes in upper tract urothelial carcinoma (UTUC)
however, there is a lack of data regarding its association with clinicopathologic features as well as survival ou
however, there is a lack of data regarding its association with clinicopathologic features as well as survival ou
Autor:
Ekaterina, Laukhtina, Ursula, Lemberger, Andreas, Bruchbacher, Dafina, Ilijazi, Stephan, Korn, Florian, Berndl, David, D'Andrea, Martin, Susani, Dmitry, Enikeev, Eva, Compérat, Shahrokh F, Shariat, Melanie R, Hassler
Publikováno v:
Journal of Personalized Medicine
The gene coding for histone methyltransferase KMT2D is found among the top mutated genes in upper tract urothelial carcinoma (UTUC); however, there is a lack of data regarding its association with clinicopathologic features as well as survival outcom